Cross Fiber Fascial Manipulation and Stretching Techniques in Overhead Throwing Athletes
Comparative Effects of Cross Fiber Fascial Manipulation and Stretching Techniques on Glenohumeral Internal Rotation Deficit in Overhead Throwing Athletes
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Aqsa Nawaz, MS
- Phone Number: 03083907800
- Email: aqsanawaz809@gmail.com
Study Locations
-
-
Punjab
-
Lahore, Punjab, Pakistan, 5433
- Recruiting
- Pakistan sports board
-
Contact:
- Aqsa Nawaz, MS SPORTS PT
- Phone Number: 03083907800
- Email: aqsanawaz809@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Active male and female athletes were included.
- Age group was (18-40) .
- Overhead throwing athletes(tennis, volleyball, bowlers) were included in this study)
- Screening tests were taken to identify subjects with GIRD. GIRD was defined as more than 20o decrease in IR at 90o abduction in the dominant side compared to non-dominant side .
- Subjects who rated shoulder pain 5 or more in NPRS/symptomatic with GIRD were recruited
Exclusion Criteria :
- Any deformity
- Any radiculopathy
- Shoulder traumatic injuries( dislocation, subluxation, fracture)
- Systemic illness
- Subacromial impingement signs
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: cross fiber fascial manipulation
The group A received three sessions of fascial manipulation in two weeks.
FM applied to densified Centre of Coordination (CC) points located on the myofascial sequences for 5 to 8 minutes at each CC point
|
The group A received three sessions of fascial manipulation in two weeks.
FM applied for 5 to 8 minutes at each point.
|
|
Experimental: stretching techniques
Group B received three sessions of sleeper and cross body adduction stretches.
Group B received three sessions of sleeper stretch in a side lying position in 90o abduction, elbow at 90o flexion and then performing shoulder IR and cross-body adduction stretch was done in sitting position.
Three sets of the each stretch position were held for 30 seconds with a 1 minute break between sets
|
Group B received three sessions of sleeper and cross body adduction stretches.
Group B received three sessions of sleeper stretch in a side lying position in 90o abduction, elbow at 90o flexion and then performing shoulder IR and cross-body adduction stretch was done in sitting position.
Three sets of the each stretch position were held for 30 seconds with a 1 minute break between sets.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Goniometer
Time Frame: 2 weeks
|
A universal goniometer was used to assess internal rotation, external rotation and horizontal adduction
|
2 weeks
|
|
numeric pain rating scale
Time Frame: 2 weeks
|
NPRS for pain assessment in overhead athletes reporting pain with GIRD, it is a subjective measure in which individual rate their pain on an 11-point numerical scale.
The scale is composed of 0 (no pain at all) to 10( worst pain
|
2 weeks
|
|
ROWE score composite
Time Frame: 2 weeks
|
ROWE score for shoulder functional assessment(50), stability(30), pain(10) and motion(10).
Total score is 100 thus 90-100=excellent ,70-89=good , 40-69=fair , less than 40 points=poor
|
2 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: aqsa nawaz, MS SPORTS pt, Riphah International University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- REC/RCR&AHS/22/0408
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.